The immunohistochemical results showed that the Ki-67 staining of the RAD21 overexpression group was darker than that of the control group, indicating the pro-proliferative role of RAD21 in ovarian cancer (Figure 6E). The gene discussed is RAD21; the disease is ovarian carcinoma.